The expanded label approves Maci in knee arthroscopy to repair symptomatic single or multiple full-thickness cartilage defects up to 4 cm. Maci Arthro is a less invasive technique compared to the standard approach and lets surgeons deliver the implant through small incisions.
Maci is a cellularized scaffold that uses tissue engineering processes to grow cells using cartilage tissue from the patient’s own knee. It is the only restorative biologic cartilage repair approved for arthroscopic administration.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
